ImmunityBio, Inc. (IBRX): A Bull Case Theory 

We came across a bullish thesis on ImmunityBio, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on IBRX. ImmunityBio, Inc.’s share was trading at $2.30 as of December 1st.

ImmunityBio (IBRX) is positioning itself at the forefront of one of the most pressing medical challenges—widespread immune exhaustion and lymphopenia, where reduced lymphocyte counts weaken the...